Byung Kyun Ko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Byung Kyun Ko has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Jeong Woo Park
School of Biological Sciences, University of Ulsan, Ulsan, Korea
2 shared publications - Anh-Nhung Le
Department of Biological Sciences, University of Ulsan, Ulsan 44610, Korea
1 shared publication Beom Chang Kim
Department of Biological Sciences, University of Ulsan, Ulsan, 680-749, South Korea
1 shared publicationByung Ju Lee
Department of Biological Sciences, University of Ulsan, Ulsan, 680-749, South Korea
1 shared publication- Byung Ju Lee
Department of Biological Sciences, University of Ulsan, Ulsan, Republic of Korea
1 shared publication - Chang Man Ha
Research Division and Brain Research Core Facilities of Korea Brain Research Institute, Daegu 41068, Korea
1 shared publication
Latest Publications
- Open Access
- 6 March 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (5) , 2877
DRG2 Depletion Promotes Endothelial Cell Senescence and Vascular Endothelial Dysfunction
Endothelial cell senescence is involved in endothelial dysfunction and vascular diseases. However, the detailed mechanisms of endothelial senescence are not fully understood. Here, we demonstrated that deficiency of developmentally regulated GTP-binding protein 2 (DRG2) induces senescence and dysfunction of endothelial cells. DRG2 knockout (KO) mice displayed reduced cerebral blood flow in the brain and lung blood vessel density. We also determined, by Matrigel plug assay, aorta ring assay, and in vitro tubule formation of primary lung endothelial cells, that deficiency in DRG2 reduced the angiogenic capability of endothelial cells. Endothelial cells from DRG2 KO mice showed a senescence phenotype with decreased cell growth and enhanced levels of p21 and phosphorylated p53, γH2AX, senescence-associated β-galactosidase (SA-β-gal) activity, and senescence-associated secretory phenotype (SASP) cytokines. DRG2 deficiency in endothelial cells upregulated arginase 2 (Arg2) and generation of reactive oxygen species. Induction of SA-β-gal activity was prevented by the antioxidant N-acetyl cysteine in endothelial cells from DRG2 KO mice. In conclusion, our results suggest that DRG2 is a key regulator of endothelial senescence, and its downregulation is probably involved in vascular dysfunction and diseases.
- 6 March 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (5) , 2877
Open AccessDRG2 Depletion Promotes Endothelial Cell Senescence and Vascular Endothelial Dysfunction
Endothelial cell senescence is involved in endothelial dysfunction and vascular diseases. However, the detailed mechanisms of endothelial senescence are not fully understood. Here, we demonstrated that deficiency of developmentally regulated GTP-binding protein 2 (DRG2) induces senescence and dysfunction of endothelial cells. DRG2 knockout (KO) mice displayed reduced cerebral blood flow in the brain and lung blood vessel density. We also determined, by Matrigel plug assay, aorta ring assay, and in vitro tubule formation of primary lung endothelial cells, that deficiency in DRG2 reduced the angiogenic capability of endothelial cells. Endothelial cells from DRG2 KO mice showed a senescence phenotype with decreased cell growth and enhanced levels of p21 and phosphorylated p53, γH2AX, senescence-associated β-galactosidase (SA-β-gal) activity, and senescence-associated secretory phenotype (SASP) cytokines. DRG2 deficiency in endothelial cells upregulated arginase 2 (Arg2) and generation of reactive oxygen species. Induction of SA-β-gal activity was prevented by the antioxidant N-acetyl cysteine in endothelial cells from DRG2 KO mice. In conclusion, our results suggest that DRG2 is a key regulator of endothelial senescence, and its downregulation is probably involved in vascular dysfunction and diseases.
- 1 February 2020
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 522 (2) , 402-407
Doxorubicin inhibits PD-L1 expression by enhancing TTP-mediated decay of PD-L1 mRNA in cancer cells
- 1 February 2020
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 522 (2) , 402-407
Doxorubicin inhibits PD-L1 expression by enhancing TTP-mediated decay of PD-L1 mRNA in cancer cells